Procés de debat i consulta del Pla de Drets Humans de Catalunya

#ÀgoraDeDrets Volem que la ciutadania digui la seva respecte a les mesures proposades per a cada un dels drets humans que conformen el pla

Fase 1 de 1

Àgora Virtual del Pla de Drets Humans de Catalunya 06/06/2019 - 31/07/2019

Fases del procés

Canvis a "Examining Epilepsy Monitoring Devices Market Growth and Size for Strategic Decision-Making"

Mode de vista de comparació:

Títol

+{"es"=>"Examining Epilepsy Monitoring Devices Market Growth and Size for Strategic Decision-Making"}

Cos

+["The global epilepsy monitoring devices market size was USD 484.6 Million in 2021 and is expected to register a rapid revenue CAGR of 4.5% during the forecast period. The global epilepsy monitoring devices market is expected to grow at a significant rate in the coming years, owing to the rising prevalence of epilepsy and the increasing demand for non-invasive diagnostic procedures. Epilepsy is a neurological disorder characterized by recurrent seizures that can significantly impact a person's quality of life. According to the World Health Organization (WHO), epilepsy affects approximately 50 million people worldwide, with 80% of these individuals residing in low- and middle-income countries.\n\nThe growing incidence of epilepsy is one of the major drivers of the epilepsy monitoring devices market. In addition, the increasing availability of advanced technologies for diagnosis and treatment is also fueling market growth. For instance, the development of wireless technology and the miniaturization of sensors has enabled the production of portable and easy-to-use epilepsy monitoring devices, which are becoming increasingly popular among patients.\n\nThis market intelligence assessment report weighs up on the potential region that reserves greater opportunities for this industry. Importantly, subject matter experts have taken into account every critical aspect right from the market size, share, and growth to the dramatic shift in the consumer behaviour and their growing spending capacity. The industry assessment study depicts a perfectly clear picture of both the past and the future trends to offer the stakeholders, business owners, and marketing executives an opportunity to zero in on an effective marketing strategy and boost sales.\n\nRequest a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1840\n\nCompetitive Terrain:\n\nThe section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Epilepsy Monitoring Devices market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.\n\nThe leading market contenders listed in the report are:\n\nSK Biopharmaceuticals, UCB S.A., Novartis AG, GSK Plc, Pfizer Inc., Eisai Co, Ltd., Angelini Pharma, Indoco Remedies Ltd, Sun Pharmaceuticals Industries Ltd., and Abbott\n\nClick to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/epilepsy-monitoring-devices-market\n\nEmergen Research has segmented the global Epilepsy Monitoring Devices market on the basis of type, application, end-use, and region:\n\nSegments Covered in this report are:\n\nProduct Portability Outlook (Revenue, USD Million; 2019-2030)\nConventional Devices\nMonitoring Devices\nDeep Brain Stimulation Devices\nWearable Devices\nEnd-use Outlook (Revenue, USD Million; 2019-2030)\nHospitals\nNeurology Centers\nAmbulatory Surgery Centers (ASCs) & Clinics\nDiagnostics Centers\nOthers\nRegional Outlook (Revenue, USD Million; 2019–2030)\nNorth America\nU.S.\nCanada\nMexico\nEurope\nGermany\nFrance\nUK\nItaly\nSpain\nBenelux\nRest of Europe\nAsia Pacific\nChina\nIndia\nJapan\nSouth Korea\nRest of APAC\nLatin America\nBrazil\nRest of LATAM\nMiddle East & Africa\nSaudi Arabia\nUAE\nSouth Africa\nTurkey\nRest of Middle East & Africa\nThe various regions analyzed in the report include:\n\nNorth America (U.S., Canada)\nEurope (U.K., Italy, Germany, France, Rest of EU)\nAsia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)\nLatin America (Chile, Brazil, Argentina, Rest of Latin America)\nMiddle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)\nKey Objectives of the Report:\n\nAnalysis and estimation of the Epilepsy Monitoring Devices Market size and share for the projected period of 2022-2030\nExtensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape\nStudy of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Epilepsy Monitoring Devices Market\nAnalysis of the growth prospects for the stakeholders and investors through the study of the promising segments\nStrategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities\nRequest Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1840\ngid://decidim-barcelona-organizations/Decidim::Hashtag/37/_ÀgoraDeDrets gid://decidim-barcelona-organizations/Decidim::Hashtag/38/_ÀgoraVirtual"]

+["The global epilepsy monitoring devices market size was USD 484.6 Million in 2021 and is expected to register a rapid revenue CAGR of 4.5% during the forecast period. The global epilepsy monitoring devices market is expected to grow at a significant rate in the coming years, owing to the rising prevalence of epilepsy and the increasing demand for non-invasive diagnostic procedures. Epilepsy is a neurological disorder characterized by recurrent seizures that can significantly impact a person's quality of life. According to the World Health Organization (WHO), epilepsy affects approximately 50 million people worldwide, with 80% of these individuals residing in low- and middle-income countries.\n\nThe growing incidence of epilepsy is one of the major drivers of the epilepsy monitoring devices market. In addition, the increasing availability of advanced technologies for diagnosis and treatment is also fueling market growth. For instance, the development of wireless technology and the miniaturization of sensors has enabled the production of portable and easy-to-use epilepsy monitoring devices, which are becoming increasingly popular among patients.\n\nThis market intelligence assessment report weighs up on the potential region that reserves greater opportunities for this industry. Importantly, subject matter experts have taken into account every critical aspect right from the market size, share, and growth to the dramatic shift in the consumer behaviour and their growing spending capacity. The industry assessment study depicts a perfectly clear picture of both the past and the future trends to offer the stakeholders, business owners, and marketing executives an opportunity to zero in on an effective marketing strategy and boost sales.\n\nRequest a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1840\n\nCompetitive Terrain:\n\nThe section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Epilepsy Monitoring Devices market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.\n\nThe leading market contenders listed in the report are:\n\nSK Biopharmaceuticals, UCB S.A., Novartis AG, GSK Plc, Pfizer Inc., Eisai Co, Ltd., Angelini Pharma, Indoco Remedies Ltd, Sun Pharmaceuticals Industries Ltd., and Abbott\n\nClick to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/epilepsy-monitoring-devices-market\n\nEmergen Research has segmented the global Epilepsy Monitoring Devices market on the basis of type, application, end-use, and region:\n\nSegments Covered in this report are:\n\nProduct Portability Outlook (Revenue, USD Million; 2019-2030)\nConventional Devices\nMonitoring Devices\nDeep Brain Stimulation Devices\nWearable Devices\nEnd-use Outlook (Revenue, USD Million; 2019-2030)\nHospitals\nNeurology Centers\nAmbulatory Surgery Centers (ASCs) & Clinics\nDiagnostics Centers\nOthers\nRegional Outlook (Revenue, USD Million; 2019–2030)\nNorth America\nU.S.\nCanada\nMexico\nEurope\nGermany\nFrance\nUK\nItaly\nSpain\nBenelux\nRest of Europe\nAsia Pacific\nChina\nIndia\nJapan\nSouth Korea\nRest of APAC\nLatin America\nBrazil\nRest of LATAM\nMiddle East & Africa\nSaudi Arabia\nUAE\nSouth Africa\nTurkey\nRest of Middle East & Africa\nThe various regions analyzed in the report include:\n\nNorth America (U.S., Canada)\nEurope (U.K., Italy, Germany, France, Rest of EU)\nAsia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)\nLatin America (Chile, Brazil, Argentina, Rest of Latin America)\nMiddle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)\nKey Objectives of the Report:\n\nAnalysis and estimation of the Epilepsy Monitoring Devices Market size and share for the projected period of 2022-2030\nExtensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape\nStudy of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Epilepsy Monitoring Devices Market\nAnalysis of the growth prospects for the stakeholders and investors through the study of the promising segments\nStrategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities\nRequest Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1840\ngid://decidim-barcelona-organizations/Decidim::Hashtag/37/_ÀgoraDeDrets gid://decidim-barcelona-organizations/Decidim::Hashtag/38/_ÀgoraVirtual"]

Esborrats

Addicions

+["The global epilepsy monitoring devices market size was USD 484.6 Million in 2021 and is expected to register a rapid revenue CAGR of 4.5% during the forecast period. The global epilepsy monitoring devices market is expected to grow at a significant rate in the coming years, owing to the rising prevalence of epilepsy and the increasing demand for non-invasive diagnostic procedures. Epilepsy is a neurological disorder characterized by recurrent seizures that can significantly impact a person's quality of life. According to the World Health Organization (WHO), epilepsy affects approximately 50 million people worldwide, with 80% of these individuals residing in low- and middle-income countries.\n\nThe growing incidence of epilepsy is one of the major drivers of the epilepsy monitoring devices market. In addition, the increasing availability of advanced technologies for diagnosis and treatment is also fueling market growth. For instance, the development of wireless technology and the miniaturization of sensors has enabled the production of portable and easy-to-use epilepsy monitoring devices, which are becoming increasingly popular among patients.\n\nThis market intelligence assessment report weighs up on the potential region that reserves greater opportunities for this industry. Importantly, subject matter experts have taken into account every critical aspect right from the market size, share, and growth to the dramatic shift in the consumer behaviour and their growing spending capacity. The industry assessment study depicts a perfectly clear picture of both the past and the future trends to offer the stakeholders, business owners, and marketing executives an opportunity to zero in on an effective marketing strategy and boost sales.\n\nRequest a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1840\n\nCompetitive Terrain:\n\nThe section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Epilepsy Monitoring Devices market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.\n\nThe leading market contenders listed in the report are:\n\nSK Biopharmaceuticals, UCB S.A., Novartis AG, GSK Plc, Pfizer Inc., Eisai Co, Ltd., Angelini Pharma, Indoco Remedies Ltd, Sun Pharmaceuticals Industries Ltd., and Abbott\n\nClick to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/epilepsy-monitoring-devices-market\n\nEmergen Research has segmented the global Epilepsy Monitoring Devices market on the basis of type, application, end-use, and region:\n\nSegments Covered in this report are:\n\nProduct Portability Outlook (Revenue, USD Million; 2019-2030)\nConventional Devices\nMonitoring Devices\nDeep Brain Stimulation Devices\nWearable Devices\nEnd-use Outlook (Revenue, USD Million; 2019-2030)\nHospitals\nNeurology Centers\nAmbulatory Surgery Centers (ASCs) & Clinics\nDiagnostics Centers\nOthers\nRegional Outlook (Revenue, USD Million; 2019–2030)\nNorth America\nU.S.\nCanada\nMexico\nEurope\nGermany\nFrance\nUK\nItaly\nSpain\nBenelux\nRest of Europe\nAsia Pacific\nChina\nIndia\nJapan\nSouth Korea\nRest of APAC\nLatin America\nBrazil\nRest of LATAM\nMiddle East & Africa\nSaudi Arabia\nUAE\nSouth Africa\nTurkey\nRest of Middle East & Africa\nThe various regions analyzed in the report include:\n\nNorth America (U.S., Canada)\nEurope (U.K., Italy, Germany, France, Rest of EU)\nAsia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)\nLatin America (Chile, Brazil, Argentina, Rest of Latin America)\nMiddle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)\nKey Objectives of the Report:\n\nAnalysis and estimation of the Epilepsy Monitoring Devices Market size and share for the projected period of 2022-2030\nExtensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape\nStudy of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Epilepsy Monitoring Devices Market\nAnalysis of the growth prospects for the stakeholders and investors through the study of the promising segments\nStrategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities\nRequest Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1840\ngid://decidim-barcelona-organizations/Decidim::Hashtag/37/_ÀgoraDeDrets gid://decidim-barcelona-organizations/Decidim::Hashtag/38/_ÀgoraVirtual"]

Esborrats

Addicions

+["The global epilepsy monitoring devices market size was USD 484.6 Million in 2021 and is expected to register a rapid revenue CAGR of 4.5% during the forecast period. The global epilepsy monitoring devices market is expected to grow at a significant rate in the coming years, owing to the rising prevalence of epilepsy and the increasing demand for non-invasive diagnostic procedures. Epilepsy is a neurological disorder characterized by recurrent seizures that can significantly impact a person's quality of life. According to the World Health Organization (WHO), epilepsy affects approximately 50 million people worldwide, with 80% of these individuals residing in low- and middle-income countries.\n\nThe growing incidence of epilepsy is one of the major drivers of the epilepsy monitoring devices market. In addition, the increasing availability of advanced technologies for diagnosis and treatment is also fueling market growth. For instance, the development of wireless technology and the miniaturization of sensors has enabled the production of portable and easy-to-use epilepsy monitoring devices, which are becoming increasingly popular among patients.\n\nThis market intelligence assessment report weighs up on the potential region that reserves greater opportunities for this industry. Importantly, subject matter experts have taken into account every critical aspect right from the market size, share, and growth to the dramatic shift in the consumer behaviour and their growing spending capacity. The industry assessment study depicts a perfectly clear picture of both the past and the future trends to offer the stakeholders, business owners, and marketing executives an opportunity to zero in on an effective marketing strategy and boost sales.\n\nRequest a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1840\n\nCompetitive Terrain:\n\nThe section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Epilepsy Monitoring Devices market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.\n\nThe leading market contenders listed in the report are:\n\nSK Biopharmaceuticals, UCB S.A., Novartis AG, GSK Plc, Pfizer Inc., Eisai Co, Ltd., Angelini Pharma, Indoco Remedies Ltd, Sun Pharmaceuticals Industries Ltd., and Abbott\n\nClick to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/epilepsy-monitoring-devices-market\n\nEmergen Research has segmented the global Epilepsy Monitoring Devices market on the basis of type, application, end-use, and region:\n\nSegments Covered in this report are:\n\nProduct Portability Outlook (Revenue, USD Million; 2019-2030)\nConventional Devices\nMonitoring Devices\nDeep Brain Stimulation Devices\nWearable Devices\nEnd-use Outlook (Revenue, USD Million; 2019-2030)\nHospitals\nNeurology Centers\nAmbulatory Surgery Centers (ASCs) & Clinics\nDiagnostics Centers\nOthers\nRegional Outlook (Revenue, USD Million; 2019–2030)\nNorth America\nU.S.\nCanada\nMexico\nEurope\nGermany\nFrance\nUK\nItaly\nSpain\nBenelux\nRest of Europe\nAsia Pacific\nChina\nIndia\nJapan\nSouth Korea\nRest of APAC\nLatin America\nBrazil\nRest of LATAM\nMiddle East & Africa\nSaudi Arabia\nUAE\nSouth Africa\nTurkey\nRest of Middle East & Africa\nThe various regions analyzed in the report include:\n\nNorth America (U.S., Canada)\nEurope (U.K., Italy, Germany, France, Rest of EU)\nAsia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)\nLatin America (Chile, Brazil, Argentina, Rest of Latin America)\nMiddle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)\nKey Objectives of the Report:\n\nAnalysis and estimation of the Epilepsy Monitoring Devices Market size and share for the projected period of 2022-2030\nExtensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape\nStudy of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Epilepsy Monitoring Devices Market\nAnalysis of the growth prospects for the stakeholders and investors through the study of the promising segments\nStrategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities\nRequest Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1840\ngid://decidim-barcelona-organizations/Decidim::Hashtag/37/_ÀgoraDeDrets gid://decidim-barcelona-organizations/Decidim::Hashtag/38/_ÀgoraVirtual"]

Número de versió 1 de 1 Mostra totes les versions Torna a la proposta

Autoria de la versió

ishadeshpande

Versió creada el 06/06/2024 07:18